Tonix Pharmaceuticals Secures $34 Million Contract with US Defense Department for Antiviral Development

1. Contract Award: Tonix Pharmaceuticals has been awarded a $34 million contract by the US Defense Department to develop an antiviral.
2. Contract Duration: The contract is for a period of five years.
3. Development Focus: The contract is focused on the development of an antiviral, with Tonix Pharmaceuticals working closely with the US Defense Department.
4. Announcement Date: The contract was announced on July 22, 2024.
5. Source: The information was reported by FirstWord Pharma and confirmed by Tonix Pharmaceuticals.